Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Eur Rev Med Pharmacol Sci ; 28(3): 939-948, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38375699

ABSTRACT

OBJECTIVE: Cone Beam Computed Tomography (CBCT) was used to observe and describe the distribution of canalis sinuosus (CS) in the Chinese population and the location of CS in the maxillary alveolar bone, so as to help oral surgeons evaluate the intraoperative risk and prognosis before maxillary surgery and reduce the complications caused by the injury of this structure in anterior surgery. PATIENTS AND METHODS: CBCT images of 600 patients admitted from 2021 to 2022 were collected to observe the anatomical structure of CS in the maxillary region. The following parameters were recorded: age, sex, number of CS, left and right distribution of CS, CS diameter, and location. Statistical analysis was performed on all of the collected data. RESULTS: The discovery rate of CS in this study was 59.75%, and it is commonly found in the lateral incisor area (64.82%). No significant difference can be found in the presence and number of CS in different gender and age groups (p>0.05). CONCLUSIONS: The use of high-resolution CBCT before implantation is of irreplaceable significance in the diagnosis and analysis of CS, which is conducive to reducing implantation complications and failure rate. The incidence of CS was independent of age or sex, while the location of CS was statistically significant.


Subject(s)
Cone-Beam Computed Tomography , Maxilla , Humans , Cone-Beam Computed Tomography/methods , Maxilla/diagnostic imaging , Maxilla/surgery , Data Collection , Embryo Implantation , Gastrointestinal Tract
2.
Eur Rev Med Pharmacol Sci ; 21(4): 765-774, 2017 02.
Article in English | MEDLINE | ID: mdl-28272706

ABSTRACT

OBJECTIVE: Dysfunctional metabolisms have contributed towards ischemia-reperfusion (I/R) injury. However, the role of remote ischemic preconditioning (RIP) in I/R injury is not well known. The present study showed alleviated I/R injury in kidneys treated with RIP. MATERIALS AND METHODS: We utilized GC/MS-based metabolomics to characterize the variation of metabolomes. RESULTS: Metabolic category using differential metabolites showed the lower percentage of amino acids in I/R group in comparison to RIP+I/R group, confirming the importance of amino acid metabolism in RIP-treated rat kidney. Further, pathway enrichment analysis showed alanine, aspartate and glutamate metabolism to be involved in the beneficial effects of RIP during renal I/R injury. Furthermore, another crucial enrichment pathway is biosynthesis of unsaturated fatty acids. Other vital metabolites detected in independent component analysis (ICA) analysis were d-glucose, lactic acid and cholesterol. The variation tendency of above-mentioned metabolites was overall consistent with the protective nature of RIP. CONCLUSIONS: These findings elicited a viewpoint that metabolic strategy affected by RIP are linked to underlying mechanisms of RIP and highlighted the importance of metabolic strategy against I/R injury.


Subject(s)
Ischemic Preconditioning/methods , Kidney/physiopathology , Metabolome , Reperfusion Injury , Animals , Female , Gas Chromatography-Mass Spectrometry , Kidney/metabolism , Metabolomics , Rats, Sprague-Dawley
3.
Genet Mol Res ; 14(4): 13812-22, 2015 Oct 30.
Article in English | MEDLINE | ID: mdl-26535696

ABSTRACT

The aim of this study was to understand the effect of autologous bone powder graft repair of partial mandibular defects of rabbits by the quantitative detection of bone formation. New Zealand rabbits (N = 18) were selected as the test objects, and subjected to bilateral partial mandibular defect induction. One side of the mandibular defect acted as the test group, upon which the autologous bone powder backfilling graft was performed; the other side was put aside and acted as the negative control group. All used an autogenous control. At the twelfth postoperative week, the animals were sacrificed, and semi-automatic image analysis was used to conduct bone histomorphometric detection. Immediately subsequent, quantitative detection of bone formation was performed in the test group. Fluorescent perimeter percent, mineralization apposition rate, and bone formation rate were selected as the dynamic indicators; and trabecular area percent, trabecular thickness, trabecular number, and trabecular separation degree were selected as the static indicators for single factorial variance testing. It was found that the values of P are less than 0.05 between the test group and the control group, indicating that the effect of autologous bone powder graft repair on partial mandibular defects in rabbits was positive.


Subject(s)
Bone Transplantation , Mandibular Injuries/diagnosis , Mandibular Injuries/surgery , Osteogenesis , Wound Healing , Animals , Bone Transplantation/methods , Disease Models, Animal , Rabbits
4.
Eur Rev Med Pharmacol Sci ; 19(4): 586-91, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25753875

ABSTRACT

OBJECTIVE: To investigate the effects of nimotuzumab (h-R3) with cisplatin (DDP) or fluorouracil (5-FU) on human esophageal squamous cell carcinoma (ESCC) EC1 cells. MATERIALS AND METHODS: The assignment included blank control, h-R3 alone, DDP alone, 5-FU alone, h-R3 combined with DDP, and h-R3 combined with 5-FU. The cell proliferation in each group was measured by MMT method 48 h post dose. The effect on the cell cycle was determined by flow cytometry, and the effect on cell apoptosis was determined by flow cytometry and TUNEL test 48 h post dose. RESULTS: The inhibitory effect of h-R3 on the proliferation of EC1 cells was weak. The maximum inhibition rate was 10.10 ± 0.58% 48 h post dose, and the difference in the inhibition rate between the h-R3 with chemotherapeutic agents and the chemotherapeutic agent alone was not statistically significant (p > 0.05). Flow cytometry demonstrated no obvious change in the EC1 cells after h-R3 treatment (p > 0.05). Flow cytometry and TUNEL test demonstrated that the difference in the apoptosis rate between h-R3 combined with chemotherapeutic agents and blank control was not statistically significant (p > 0.05). CONCLUSIONS: h-R3 had no significant effect on human ESCC EC1 cells in vitro, with or without the combination of chemotherapeutic agents.


Subject(s)
Antibodies, Monoclonal, Humanized/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma, Squamous Cell/drug therapy , Cell Proliferation/drug effects , Cisplatin/therapeutic use , Esophageal Neoplasms/drug therapy , Fluorouracil/therapeutic use , Apoptosis/drug effects , Cell Cycle/drug effects , Cell Line, Tumor , Dose-Response Relationship, Drug , Esophageal Squamous Cell Carcinoma , Humans
6.
Transpl Infect Dis ; 13(2): 192-9, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21457422

ABSTRACT

Aspergillus osteomyelitis has been reported as a result of dissemination in solid organ transplant recipients. Vertebral osteomyelitis is one of the most common forms of Aspergillus osteomyelitis. An Aspergillus fungal ball is a rare cause of ureteral obstruction. We describe an unusual case of simultaneous vertebral osteomyelitis and ureteral obstruction caused by A. flavus in a hepatic transplant recipient, who was successfully treated with sequential intravenous and oral itraconazole solution.


Subject(s)
Aspergillosis/etiology , Aspergillus flavus/isolation & purification , Liver Transplantation/adverse effects , Lumbar Vertebrae/microbiology , Osteomyelitis/microbiology , Ureteral Obstruction/microbiology , Administration, Oral , Antifungal Agents/therapeutic use , Aspergillosis/pathology , Aspergillosis/therapy , Humans , Injections, Intravenous , Itraconazole/administration & dosage , Itraconazole/therapeutic use , Lumbar Vertebrae/pathology , Male , Middle Aged , Osteomyelitis/etiology , Osteomyelitis/pathology , Osteomyelitis/therapy , Sputum/microbiology , Ureteral Obstruction/pathology , Ureteral Obstruction/therapy
9.
Phys Rev C Nucl Phys ; 41(4): R1355-R1358, 1990 Apr.
Article in English | MEDLINE | ID: mdl-9966549
10.
Phys Rev C Nucl Phys ; 39(3): 849-852, 1989 Mar.
Article in English | MEDLINE | ID: mdl-9955273
12.
Phys Rev C Nucl Phys ; 32(4): 1432-1434, 1985 Oct.
Article in English | MEDLINE | ID: mdl-9952992
SELECTION OF CITATIONS
SEARCH DETAIL
...